-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S1KxetWLdsQBRgeZBKVfR8IczQGkISx4qHzg9xfzYJIOtoJrbV4kUbhaLlXMsvQc dyvjUh+VjVLgD+JOW6nioQ== 0001209191-05-041328.txt : 20050808 0001209191-05-041328.hdr.sgml : 20050808 20050808155819 ACCESSION NUMBER: 0001209191-05-041328 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050805 FILED AS OF DATE: 20050808 DATE AS OF CHANGE: 20050808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AUXILIUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001182129 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 233016883 BUSINESS ADDRESS: STREET 1: 160 WEST GERMANTOWN PIKE STREET 2: SUITE D-5 CITY: NORRISTOWN STATE: PA ZIP: 19401 BUSINESS PHONE: 610-239-8850 MAIL ADDRESS: STREET 1: 160 WEST GERMANTOWN PIKE STREET 2: SUITE D-5 CITY: NORRISTOWN STATE: PA ZIP: 19401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLASSON ROLF A CENTRAL INDEX KEY: 0001030325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50855 FILM NUMBER: 051006016 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE RD STREET 2: C/O ENZON INC CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 9089804500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE RD CITY: PISCATAWAY STATE: NJ ZIP: 08854 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-08-05 0 0001182129 AUXILIUM PHARMACEUTICALS INC AUXL 0001030325 CLASSON ROLF A C/O AUXILIUM PHARMACEUTICALS, INC. 40 VALLEY STREAM PARKWAY MALVERN PA 19355 1 0 0 0 Nonqualified Stock Option (Right to Buy) 4.15 2005-08-05 4 A 0 10000 0.00 A 2006-06-08 2015-06-08 Common Stock 10000 10000 D This option vests 100% on June 8, 2006 (one year after the Reporting Person was re-elected to serve as a director of the Issuer). Jennifer Evans Stacey, as Attorney-in-Fact for Rolf A. Classon 2005-08-08 EX-24.4_96674 2 poa.txt POA DOCUMENT EXHIBIT 24 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS Know all by these present, that the undersigned hereby makes, constitutes and appoints Jennifer Evans Stacey, James E. Fickenscher and Michael N. Peterson, and each of them, each with power to appoint his/her substitute, as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of the undersigned to: (1) prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Auxilium Pharmaceuticals, Inc., a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act"); (2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the foregoing attorneys-in-fact and approves and ratifies any such release of information; and (3) perform any and all other acts which in the discretion of such attorneys-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that: (1) this Limited Power of Attorney authorizes, but does not require, such attorneys-in-fact to act in their discretion on information provided to such attorneys-in-fact without independent verification of such information; (2) any documents prepared and/or executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Limited Power of Attorney will be in such form and will contain such information and disclosure as such attorneys-in-fact, in his or her discretion, deems necessary or desirable; (3) neither the Company nor such attorneys-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and (4) this Limited Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorneys-in-fact, and each of them, full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorneys-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney. This Limited Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney to be executed as of this 5th day of August, 2005. /s/ Rolf A. Classon -----END PRIVACY-ENHANCED MESSAGE-----